COVID-19 has had an impact globally with millions infected, high mortality, significant economic ramifications, travel restrictions, national lockdowns, overloaded healthcare systems, effects on healthcare workers’ health and well-being, and large amounts of funding diverted into rapid vaccine development and implementation. Patients with COVID-19, especially those who become severely ill, have frequently developed dysphagia and dysphonia. Health professionals working in the field have needed to learn about this new disease while managing these patients with enhanced personal protective equipment. Emerging research suggests differences in the clinical symptoms and journey to recovery for patients with COVID-19 in comparison to other intensive care populations. New insights from outpatient clinics also suggest distinct presentations of dysphagia and dysphonia in people after COVID-19 who were not hospitalized or severely ill. This international expert panel provides commentary on the impact of the pandemic on speech pathologists and our current understanding of dysphagia and dysphonia in patients with COVID-19, from acute illness to long-term recovery. This narrative review provides a unique, comprehensive critical appraisal of published peer-reviewed primary data as well as emerging previously unpublished, original primary data from across the globe, including clinical symptoms, trajectory, and prognosis. We conclude with our international expert opinion on what we have learnt and where we need to go next as this pandemic continues across the globe.
Objectives: This study aims to (i) investigate post-extubation dysphagia
and dysphonia amongst adults intubated with SARS-COV-2 (COVID-19) and
referred to speech and language therapy (SLT) in acute hospitals across
the Republic of Ireland (ROI) between March and June 2020; (ii) identify
variables predictive of post-extubation oral intake status and dysphonia
and (iii) establish SLT rehabilitation needs and services provided to
this cohort. Design: A multi-site prospective observational cohort study
Participants: 100 adults with confirmed COVID-19 who were intubated
across eleven acute hospital sites in ROI and who were referred to SLT
services between March and June 2020 inclusive. Main Outcome Measures:
Oral intake status, level of diet modification and perceptual voice
quality. Results: Based on initial SLT assessment, 90% required altered
oral intake and 59% required tube feeding with 36% unable for oral
intake. Age (OR 1.064; 95% CI 1.018-1.112), proning (OR 3.671; 95% CI
1.128-11.943), and pre-existing respiratory disease (OR 5.863; 95% CI
1.521-11.599) were predictors of oral intake status post-extubation.
Two-thirds (66%) presented with dysphonia post-extubation. Intubation
injury (OR 10.471; 95% CI 1.060-103.466) and pre-existing respiratory
disease (OR 24.196; 95% CI 1.609-363.78) were predictors of
post-extubation voice quality. Thirty-seven percent required dysphagia
rehabilitation post-extubation whereas 20% needed voice rehabilitation.
Dysphagia and dysphonia persisted in 27% and 37% cases respectively at
hospital discharge. Discussion: Post-extubation dysphagia and dysphonia
were prevalent amongst adults with COVID-19 across the ROI. Predictors
included iatrogenic factors and underlying respiratory disease. Prompt
evaluation and intervention is needed to minimise complications and
inform rehabilitation planning.
Parkinson's disease voice tremor is likely to be related to oscillatory movement in structures across the vocal tract rather than just the vocal folds. To progress clinical practice, more refined tools for the visual rating of tremor would be beneficial. How far voice tremor represents a functionally significant factor for speakers would also add to the literature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.